These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37659003)

  • 21. Factors Affecting Successfulness of Vaginal Pessary Use for the Treatment of Pelvic Organ Prolapse.
    Lekskulchai O; Wanichsetakul P
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S115-20. PubMed ID: 26387398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How often should shelf/Gellhorn pessaries be changed? A survey of IUGA urogynaecologists.
    Khaja A; Freeman RM
    Int Urogynecol J; 2014 Jul; 25(7):941-6. PubMed ID: 24531407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-Specific Pessaries for Pelvic Organ Prolapse Using Three-Dimensional Printing: A Pilot Study.
    Hong CX; Zhang S; Eltahawi A; Borazjani A; Kalami H; San AN; Sham D; Ameri G; McDermott CD
    Urogynecology (Phila); 2023 Sep; 29(9):732-739. PubMed ID: 36946908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.
    Wolff B; Williams K; Winkler A; Lind L; Shalom D
    Int Urogynecol J; 2017 Jul; 28(7):993-997. PubMed ID: 27942793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
    Deng M; Ding J; Ai F; Zhu L
    Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years.
    Yang J; Han J; Zhu F; Wang Y
    Arch Gynecol Obstet; 2018 Sep; 298(3):623-629. PubMed ID: 29978415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial biofilm formation on vaginal ring pessaries used for pelvic organ prolapse.
    Gould FG; Carey MP; Plummer EL; Murray GL; Danielewski JA; Tabrizi SN; Garland SM
    Int Urogynecol J; 2022 Feb; 33(2):287-295. PubMed ID: 33660005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal Pessary for Pelvic Organ Prolapse: A French Multidisciplinary Survey.
    Pizzoferrato AC; Nyangoh-Timoh K; Martin-Lasnel M; Fauvet R; de Tayrac R; Villot A
    J Womens Health (Larchmt); 2022 Jun; 31(6):870-877. PubMed ID: 34569823
    [No Abstract]   [Full Text] [Related]  

  • 29. Patient-reported goal attainment and comprehensive functioning outcomes after surgery compared with pessary for pelvic organ prolapse.
    Sung VW; Wohlrab KJ; Madsen A; Raker C
    Am J Obstet Gynecol; 2016 Nov; 215(5):659.e1-659.e7. PubMed ID: 27319365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of incarcerated vaginal pessaries.
    Poma PA
    J Am Geriatr Soc; 1981 Jul; 29(7):325-7. PubMed ID: 7240622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
    Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
    Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of questions by patients with pelvic organ prolapse about vaginal pessaries resulting in a checklist for their physicians.
    Wagner JR; Fink T; Arabin B
    Arch Gynecol Obstet; 2024 Jan; 309(1):329-337. PubMed ID: 37597024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse events associated with pessary use over one year among women attending a pessary care clinic.
    Kakkar A; Reuveni-Salzman A; Bentaleb J; Belzile E; Merovitz L; Larouche M
    Int Urogynecol J; 2023 Aug; 34(8):1765-1770. PubMed ID: 36715742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An estriol-eluting pessary to treat pelvic organ prolapse.
    Long J; Zidan G; Seyfoddin A; Tong S; Brownfoot FC; Chowdary P
    Sci Rep; 2022 Nov; 12(1):20021. PubMed ID: 36414726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users.
    Mendes LC; Bezerra LRPS; Bilhar APM; Neto JAV; Vasconcelos CTM; Saboia DM; Karbage SAL
    Int Urogynecol J; 2021 Apr; 32(4):1023-1029. PubMed ID: 33048180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonsurgical management of a rectovaginal fistula caused by a Gellhorn pessary.
    Cichowski S; Rogers RG
    Obstet Gynecol; 2013 Aug; 122(2 Pt 2):446-449. PubMed ID: 23884255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are older patients with prolapse likely to continue pessary use? A retrospective observational study.
    Dykes N; Lim YN; Zilberlicht A; Dwyer PL
    Int Urogynecol J; 2023 Dec; 34(12):2919-2923. PubMed ID: 37572122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Location and motion of vaginal pessaries in situ in women with successful and unsuccessful pessary treatment for pelvic organ prolapse.
    Boogaard LL; Triepels CPR; Verhamme LM; van Kuijk SMJ; Donners JJAE; Kluivers KB; Maal TJJ; Weemhoff M; Notten KJB
    Int Urogynecol J; 2023 Sep; 34(9):2293-2300. PubMed ID: 37119269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term Outcomes of Self-Management Gellhorn Pessary for Symptomatic Pelvic Organ Prolapse.
    Chien CW; Lo TS; Tseng LH; Lin YH; Hsieh WC; Lee SJ
    Female Pelvic Med Reconstr Surg; 2020 Nov; 26(11):e47-e53. PubMed ID: 31393340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.